+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Companion Diagnostics Market by Product Type (Immunohistochemistry, In Situ Hybridization, Next Generation Sequencing), Application (Genetic Disorders, Infectious Diseases, Oncology), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Companion Diagnostics Market by Product Type (Immunohistochemistry, In Situ Hybridization, Next Generation Sequencing), Application (Genetic Disorders, Infectious Diseases, Oncology), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Companion Diagnostics Market by Product Type (Immunohistochemistry, In Situ Hybridization, Next Generation Sequencing), Application (Genetic Disorders, Infectious Diseases, Oncology), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336915
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The companion diagnostics market is advancing rapidly, equipping health systems and pharmaceutical leaders with precision tools for targeted treatment decisions. Senior stakeholders must stay ahead of evolving integration, regulatory environments, and emerging technologies shaping this critical diagnostic sector.

Market Snapshot: Companion Diagnostics Sector Growth

The Companion Diagnostics Market grew from USD 7.30 billion in 2024 to USD 8.10 billion in 2025. It is expected to continue growing at a CAGR of 10.79%, reaching USD 13.51 billion by 2030. Industry dynamics are underpinned by the continual interplay of genomic, proteomic, and digital innovations, with stakeholder alignment across regulatory and development pipelines supporting sustainable expansion. The companion diagnostics market is characterized by intensifying collaborations between pharmaceutical companies and diagnostic developers, underpinned by accelerating adoption of high-throughput sequencing, artificial intelligence, and integrated real-time analytics within clinical workflows.

Scope & Segmentation

This report delivers in-depth analysis across diverse segmentation dimensions, presenting actionable intelligence for strategic decision-making while tracking the full competitive landscape.

  • Product Type: Immunohistochemistry, In Situ Hybridization, Next Generation Sequencing (including Targeted Sequencing, Transcriptome Sequencing, Whole Genome Sequencing), Polymerase Chain Reaction (Digital PCR, Quantitative PCR)
  • Application: Genetic Disorders, Infectious Diseases, Oncology, Pharmacogenomics
  • End User: Academic and Research Institutes, Diagnostic Laboratories, Hospitals, Pharmaceutical Companies
  • Distribution Channel: Direct Tender, Distributor Sales, Online Sales
  • Geography: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., QIAGEN N.V., Abbott Laboratories, Illumina Inc., Danaher Corporation, Becton, Dickinson and Company, bioMérieux SA, Agilent Technologies Inc., Siemens Healthineers AG

Key Takeaways for Decision-Makers

  • Companion diagnostics now drive alignment between drug and diagnostic R&D, enhancing precision medicine by bridging genomic research with clinical adoption.
  • Complex diagnostic workflows increasingly leverage high-resolution imaging, advanced multiplexed platforms, and digital pathology, supporting rapid, noninvasive biomarker detection across therapeutic areas.
  • Emerging regulatory clarity and harmonized global frameworks foster more efficient approvals, catalyzing faster product rollouts and accelerated clinical trial enrollment.
  • The shift toward decentralized testing and digital health integration empowers remote monitoring, patient-centric engagement, and dynamic resource allocation in clinical and commercial settings.
  • Strategic business models now integrate manufacturing flexibility, digital services, and data analytics to deliver tailored customer value while supporting scalability and compliance.
  • Collaborative alliances and selective acquisitions are expanding market reach and reshaping the competitive landscape, with leading players integrating hardware, software, and specialized assays.

Tariff Impact: United States Market Developments

In 2025, tariffs on key diagnostic reagents and laboratory instruments have prompted industry operators in the United States to reassess supplier networks and initiate domestic production strategies. These new financial pressures are restructuring negotiation dynamics, leading to the adoption of flexible, tiered pricing models and heightened emphasis on domestic supply chain resilience. Strategic partnerships are forming to streamline logistics, improve operational continuity, and ensure reliable access to essential consumables within this shifting regulatory environment.

Methodology & Data Sources

Insights are built on robust multi-source research, beginning with exhaustive secondary review across peer-reviewed literature, regulatory filings, company disclosures, and association reports. This was followed by structured primary interviews with over fifty senior industry experts. Data triangulation and rigorous validation underpin every segment insight and trend analysis presented in this report.

Why This Report Matters

  • Provides senior executives with targeted, actionable intelligence for strategic planning in precision diagnostics and personalized healthcare.
  • Equips market leaders with insight into evolving regulations, technology integration, supply chain resilience, and investment opportunities across major geographies.
  • Supports informed decisions on product portfolio expansion, strategic alliances, and value-driven commercial models in the diagnostic ecosystem.

Conclusion

Companion diagnostics is poised at the frontier of precision healthcare, reshaping clinical and commercial landscapes. Leaders who anticipate regulatory shifts and invest in integrated, adaptive technologies will drive sustained market growth and realize meaningful patient impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of multiomic biomarkers into companion diagnostic assays for personalized therapies
5.2. Expansion of liquid biopsy based companion diagnostics for real-time treatment monitoring
5.3. Adoption of digital pathology and AI algorithms in companion diagnostic result interpretation
5.4. Collaboration between pharmaceutical and diagnostic developers for co-development of targeted therapies
5.5. Emergence of cost-effective point-of-care companion diagnostic platforms in emerging markets
5.6. Regulatory harmonization initiatives to streamline companion diagnostic approvals across major regions
5.7. Development of multiplex companion diagnostics enabling simultaneous profiling of multiple biomarkers
5.8. Growing investment in next-generation sequencing panels for comprehensive companion diagnostic testing
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Companion Diagnostics Market, by Product Type
8.1. Introduction
8.2. Immunohistochemistry
8.3. In Situ Hybridization
8.4. Next Generation Sequencing
8.4.1. Targeted Sequencing
8.4.2. Transcriptome Sequencing
8.4.3. Whole Genome Sequencing
8.5. Polymerase Chain Reaction
8.5.1. Digital Pcr
8.5.2. Quantitative Pcr
9. Companion Diagnostics Market, by Application
9.1. Introduction
9.2. Genetic Disorders
9.3. Infectious Diseases
9.4. Oncology
9.5. Pharmacogenomics
10. Companion Diagnostics Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Pharmaceutical Companies
11. Companion Diagnostics Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tender
11.3. Distributor Sales
11.4. Online Sales
12. Americas Companion Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Companion Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Companion Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. QIAGEN N.V.
15.3.4. Abbott Laboratories
15.3.5. Illumina, Inc.
15.3.6. Danaher Corporation
15.3.7. Becton, Dickinson and Company
15.3.8. bioMérieux SA
15.3.9. Agilent Technologies, Inc.
15.3.10. Siemens Healthineers AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. COMPANION DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. COMPANION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. COMPANION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. COMPANION DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 24. COMPANION DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. COMPANION DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 26. COMPANION DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COMPANION DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 92. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 93. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 94. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 95. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 104. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 105. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 166. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 167. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 168. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 169. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 178. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 179. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 180. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 181. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 202. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 203. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 204. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 205. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 214. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 215. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 216. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 217. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 262. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 263. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 264. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 265. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 286. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 287. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 288. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 289. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 298. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 299. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 300. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 301. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA COMPANION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Abbott Laboratories
  • Illumina, Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Agilent Technologies, Inc.
  • Siemens Healthineers AG

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.51 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Companion Diagnostics Market Size, Share & Trends Analysis Report By Product And Services (Assays, Kits, & Reagents, Instruments & Systems, Software & Services), By Indication, By Technology, By Sample Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Companion Diagnostics Market Size, Share & Trends Analysis Report By Product And Services (Assays, Kits, & Reagents, Instruments & Systems, Software & Services), By Indication, By Technology, By Sample Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Oncology Companion Diagnostic Market Size, Share & Trends Analysis Report By Product & Service, By Technology (PCR, IHC, NGS), By Disease Type (Breast Cancer), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Oncology Companion Diagnostic Market Size, Share & Trends Analysis Report By Product & Service, By Technology (PCR, IHC, NGS), By Disease Type (Breast Cancer), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Companion Diagnostics Market Report and Forecast 2025-2034 - Product Image

Companion Diagnostics Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Companion Diagnostics - Global Strategic Business Report - Product Image

Companion Diagnostics - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Companion Diagnostic Tests in Oncology - Global Strategic Business Report - Product Image

Companion Diagnostic Tests in Oncology - Global Strategic Business Report

  • Report
  • 501 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.